PropertyValue
?:abstract
  • Coronavirus 19 (COVID-19) may cause a cytokine release syndrome inducing the severity of the disease Various immune modulating agents are suggested due to the lack of definitive treatment and vaccine In this case report, we aimed to share the clinical course of a Covid 19 patient who was given tocilizumab (TCZ) for severe ARDS on the 5th day of hospitalization Although, the patient was extubated 12 days after TCZ treatment with a rapid recovery, we believe that more cases are needed to determine the efficiency and timing of TCZ treatment
is ?:annotates of
?:creator
?:journal
  • International_Journal_of_Academic_Medicine_and_Pharmacy
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Using tocilizumab in sars COV-2 disease: Case report
?:type
?:who_covidence_id
  • #846469
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/h3ngx1gd>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/h3ngx1gd>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all